The World Is Preparing To Receive Vaccines ... And End The Nightmare Of Corona

The Corona virus vaccine is on the right track to spread it internationally within weeks, with increasing confidence among health officials on both sides of the Atlantic Ocean (the United States and Europe) that vaccinations will begin before the end of the year, in order to end the nightmare of the Corona virus, which has lasted for nearly a whole year.

The United Kingdom is expected to become the first country to approve a jointly developed vaccine between Pfizer and Biontech, and aims to deliver the first vaccines as soon as December 7.

American approval

US approval can be granted shortly after the December 10 FDA advisory meeting.

"It is almost possible that we will vaccinate a portion of the number one priority individuals before the end of December," Anthony Fauci, president of the US National Institute of Allergy and Infectious Diseases, told NBC.

Make preparations

In Germany, officials said, preparations have been made to ensure that people start receiving vaccinations next month, once the green light is given by European regulators.

The recommendation by these European regulators will be based on the strength of scientific evidence on the safety, quality, and effectiveness of the vaccine, and nothing else.

"As of today, we expect the Pfizer and Biontech vaccine to be approved by mid-December," German Health Minister Jens Spahn told Bavarian Radio.

Next month, the European Medicines Agency, which licenses medicines across the European Union, is set to consider whether to approve a Pfizer and Biontec vaccine and a competitor developed by Moderna, according to confidential documents reviewed by the Financial Times. The approval next month will pave the way for member states. In the 27th block, to start pollination before the end of the year.

Potential hurdles

However, there are many hurdles to overcome in the schedule, as failure with just one hurdle could push people's vaccination efforts back significantly, people familiar with the matter have warned.

The United Kingdom technically falls under the EMA's regulatory jurisdiction until 1 January, when the Brexit transition period ends, however, the UK Medicines Control Authority is able to exit the EU regulatory orbit in the event of urgent public health need under the 2012 change. In regulation.

The anti-virus agency said it will announce the date of submission of vaccine licensing applications, and will provide detailed timetables for the approval process after that.

Depending on how the assessments progress, the agency could be able to complete its evaluation of more advanced vaccine candidates at the end of this year or early next year, according to the Financial Times.

Regulators face the difficult task of striking a balance between the enormous need for public health and the need to ensure confidence in the approval process, which has become a controversial healthcare issue in some countries. Public reluctance to receive a vaccine may impede medical authorities' attempts to stop the spread of the epidemic.

People familiar with the agency's process said that the European Medicines Agency had come under pressure to speed up the process because the United Kingdom and the United States would likely agree to a vaccine soon, but in a statement the European Agency said it was "not exposed to political pressure."

She added, "The recommendation will be based on the strength of scientific evidence on the safety, quality and effectiveness of the vaccine, and nothing else," adding, "Permission will be granted when the evidence shows convincingly that the benefits of vaccination are greater than any risks of the vaccine."

Around the world, frontline health care workers and patients at risk will be the priority, and vaccine supplies are only expected to meet demand later next year.

 

SOURCE:ALQABAS

Comments Post Comment

Leave a Comment

Submit